Announced Thu, 23 Apr · 21:57 IST
Capacity Expansion at Subsidiaries Rescheduled to Phased Two-Year Plan
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.7%1-day move
₹509.00
prior close
₹511.35
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1+1.8+1.8+1.4-0.7-7.7-8.1-6.3-5.7-3.6-2.1+5.7+4.5-3.7
Up moveDown movePending
AI summary
Rossari Biotech informed that its subsidiaries, Unitop Chemicals and Tristar Intermediates, are rescheduling their capacity expansion project. Originally announced on April 24, 2025, the project will now be implemented in a phased manner over the next two years, as subsidiaries re-evaluate the investment plan due to evolving business requirements and market conditions. The overall strategic intent of the investment remains unchanged.
Likely market impact
Phased capex push to two years may temper near-term growth; strategic intent intact, reducing long-term concern.